Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 47,184 | 23,296 | 11,352 | 1,918 | 26,545 |
| Depreciation Amortization | 5,990 | 4,020 | 2,646 | 1,296 | 4,999 |
| Income taxes - deferred | 9,229 | 4,516 | 3,437 | 819 | 5,752 |
| Accounts receivable | 19,094 | 46,935 | 9,107 | 21,467 | -30,017 |
| Accounts payable and accrued liabilities | 3,392 | 5,990 | 4,151 | 1,115 | -1,547 |
| Other Working Capital | 22,957 | 36,165 | -81 | 11,691 | -25,185 |
| Other Operating Activity | -9,825 | -45,557 | -9,419 | -20,905 | 49,323 |
| Operating Cash Flow | $98,021 | $75,365 | $21,193 | $17,401 | $29,870 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,518 | 0 | N/A | N/A | N/A |
| PPE Investments | -22,101 | -14,042 | -8,631 | -5,030 | -33,287 |
| Net Acquisitions | -17,873 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 10,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-23,456 | $-14,042 | $-8,631 | $-5,030 | $-33,287 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,000 | 15,000 | 15,000 | 15,000 | 57,183 |
| Debt Repayment | -33,291 | -32,454 | -31,621 | -15,755 | -48,648 |
| Common Stock Issued | 7,235 | 4,056 | 2,784 | 1,253 | 4,464 |
| Other Financing Activity | 2,607 | 1,077 | 709 | 376 | 1,845 |
| Financing Cash Flow | $-8,449 | $-12,321 | $-13,128 | $874 | $14,844 |
| Exchange Rate Effect | -21 | -697 | -165 | 215 | 24 |
| Beginning Cash Position | 102,924 | 102,924 | 102,924 | 102,924 | 91,473 |
| End Cash Position | 169,019 | 151,229 | 102,193 | 116,384 | 102,924 |
| Net Cash Flow | $66,095 | $48,305 | $-731 | $13,460 | $11,451 |
| Free Cash Flow | |||||
| Operating Cash Flow | 98,021 | 75,365 | 21,193 | 17,401 | 29,870 |
| Capital Expenditure | -22,101 | -14,042 | -8,631 | -5,030 | -33,287 |
| Free Cash Flow | 75,920 | 61,323 | 12,562 | 12,371 | -3,417 |